Showing results (271-280 of 5,264) with videos related to

Sort By:
Pageof 527
European Journal of Haematology|May 1, 1989
Radiolabelling of human platelets with 99mTc-HMPAOM Vorne, T Honkanen, K Karppinen, et al.
European Journal of Haematology|February 1, 1987
Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case reportW Wiktor-Jedrzejczak, C Szczylik, Z Pojda, et al.
European Journal of Haematology|July 29, 2018
α-Synuclein concentration increases over time in plasma supernatant of single donor plateletsCatherine M Stefaniuk, Hong Hong, Clifford V Harding, et al.
European Journal of Haematology|May 11, 2019
Survival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL RegistryEmma Lennmyr, Karin Karlsson, Lucia Ahlberg, et al.
European Journal of Haematology|October 18, 2018
Comparative risk of major bleeding with rivaroxaban and warfarin: Population-based cohort study of unprovoked venous thromboembolismChristine G Kohn, Thomas J Bunz, Jan Beyer-Westendorf, et al.
European Journal of Haematology|April 9, 2019
Impact of cyclosporine A concentration on acute graft-vs-host disease incidence after haploidentical hematopoietic cell transplantationNicolas Stocker, Remy Duléry, Giorgia Battipaglia, et al.
European Journal of Haematology|April 26, 2018
Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progressionWen-Jun Wang, Chao-Feng Zheng, Zhuang Liu, et al.
European Journal of Haematology|July 21, 2018
Long-term clinical outcomes of patients with hematologically unexplained cytopenia after routine assessment: A single center studyMorten Munk Johansen, Michael Asger Andersen, Kirsten Grønbaek, et al.
European Journal of Haematology|July 21, 2018
Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practiceEvangelos Terpos, Eirini Katodritou, Javier de la Rubia, et al.
European Journal of Haematology|October 30, 2021
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patientsFortunato Morabito, Elena Zamagni, Concetta Conticello, et al.
Pageof 527